Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
Open Access
Abstract
Chronic hepatitis B (CHB) caused by HBV infection has brought suffering to numerous people. Due to the stable existence of HBV cccDNA, the original template for HBV replication, chronic hepatitis B (CHB) is difficult to cure completely. Despite current antiviral strategies being able to effectively limit the progression of CHB, complete CHB cure requires directly targeting HBV cccDNA. In this review, we discuss strategies that may achieve a complete cure of CHB, including inhibition of cccDNA de novo synthesis, targeting cccDNA degradation through host factors and small molecules, CRISP-Cas9-based cccDNA editing, and silencing cccDNA epigenetically.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFA1800200, 24CXRC0153, 32241009)
- Sichuan Provincial Science and Technology Innovation Talents (2023YFA1800200, 24CXRC0153, 32241009)
- National Natural Science Foundation of China (2023YFA1800200, 24CXRC0153, 32241009)
This publication has 107 references indexed in Scilit:
- Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replicationJournal of Medical Virology, 2023
- The HBV web: An insight into molecular interactomes between the hepatitis B virus and its host en route to hepatocellular carcinomaJournal of Medical Virology, 2023
- HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcriptionAntiviral Research, 2019
- HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 ProteinHepatology, 2019
- Pevonedistat, a Neuronal Precursor Cell‐Expressed Developmentally Down‐Regulated Protein 8–Activating Enzyme Inhibitor, Is a Potent Inhibitor of Hepatitis B VirusHepatology, 2018
- SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3‐9 homolog 1 and SET domain containing 1A histone methyltransferasesHepatology, 2018
- PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidationHepatology, 2017
- Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategiesAntiviral Research, 2015
- Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replicationAntiviral Research, 2015
- Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune toleranceHepatology, 2013